欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3657/001
药品名称Erlotinib Sandoz 25 mg, film-coated tablets
活性成分
    • erlotinib hydrochloride 25.0 mg
剂型Film-coated tablet
上市许可持有人Sandoz B.V. Veluwezoom 22, 1327 AH Almere The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Erlotinib Sandoz 25 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Slovakia (SK)
      Erlotinib Sandoz 25 mg
    • Belgium (BE)
    • Czechia (CZ)
      Erlotinib Sandoz 25 mg
    • Germany (DE)
      Elortinib HEXAL 25 mg Filmtabletten
    • Denmark (DK)
      Erlotinib "Sandoz"
    • Estonia (EE)
    • Spain (ES)
    • France (FR)
    • Croatia (HR)
    • Hungary (HU)
    • Ireland (IE)
    • Lithuania (LT)
      Erlotinib Sandoz 25 mg plėvele dengtos tabletės
    • Latvia (LV)
    • Poland (PL)
      Erlotinib Sandoz
    • Portugal (PT)
    • Romania (RO)
    • Sweden (SE)
    • Slovenia (SI)
许可日期2017/03/15
最近更新日期2017/10/06
药物ATC编码
    • L01XE03 erlotinib
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase